Although hepatocytes do not typically express vimentin, adipocytes do, and therefore, vimentin could be involved in mechanosensitive processes that affect the interplay between these two key cell types in MASLD and obesity. This evidence concerns the gene VIM and metabolic dysfunction-associated steatotic liver disease.